Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2
BioVie Inc. (BIVI) has invited investors to a live webinar and Q&A session on June 2, 2026, at 4:15 p.m. ET. The event is hosted by RedChip Companies and will feature CEO Cuong Do discussing the company’s pipeline, including bezisterim (NE3107) for neurological diseases and BIV201 for liver disease.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.